BioCentury | Oct 16, 2020
Product Development
Recent Phase III disappointment aside, the heart failure pipeline holds plenty to look forward to
...cGMP production via different routes. PL-3994 from Palatin Technologies Inc....
...to enter Phase II testing this quarter. Palatin...
...to enter Phase II testing this quarter. Palatin...